Reactions Weekly

, Volume 1658, Issue 1, pp 361–361 | Cite as

Osimertinib

First report of severe aplastic-anaemia: case report
Case report
  • 29 Downloads

Reference

  1. Ogata H, et al. Severe Aplastic Anemia during Osimertinib Therapy in a Patient with EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 12: e46-e47, No. 5, May 2017. Available from: URL: http://doi.org/10.1016/j.jtho.2016.12.023 - Japan

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations